A Randomized Trial Comparing High Definition Colonoscopy Alone With High Definition Dye Spraying and Electronic Virtual Chromoendoscopy for Detection of Colonic Neoplastic Lesions During IBD Surveillance Colonoscopy. Iacucci M et al. Am J Gastroenterol. 2017 Nov 14. [Epub ahead of print]
Multiple plastic stents versus covered metal stent for treatment of anastomotic biliary strictures after liver transplantation:a prospective, randomized, multicenter trial
Indicators of suboptimal tumor necrosis factor antagonist therapy in inflammatory bowel disease. Lindsay JO, Armuzzi A, Gisbert JP et al. Dig Liver Dis. 2017 Oct;49(10):1086-1091
Stent as bridge to surgery for left-sided malignant colonic obstruction reduces adverse events and stoma rate compared with emergency surgery: results of a systematic review and meta-analysis of randomized controlled trials
Infliximab Trough Levels at Induction to Predict Treatment Failure During Maintenance. Liefferinckx C et al. Inflamm Bowel Dis. 2017 Aug;23(8):1371-1381
Development of quality indicators for endoscopic eradicationtherapies in Barrett’s esophagus: the TREAT-BE (Treatmentwith Resection and Endoscopic Ablation Techniques forBarrett’s Esophagus) Consortium
Sands BE et al. Efficacy and Safety of MEDI2070, an antibody against interleukin 23, patients with moderate to severe Crohn's disease: a phase 2a study. Gastroenterology. 2017 Apr 5. [Epub ahead of print]
Pekka H et al, Performing routine follow-up biopsy 1 year after diagnosis does not affectlong-term outcomes in coeliac disease. Aliment Pharmacol Ther. 2017 Mar 21. doi: 10.1111/apt.14048
Validation of the AFP model as a predictor of HCC recurrence in patients with viral hepatitis-related cirrhosis who had received a liver transplant for HCC
Multidonor intensive faecal microbiota transplantation for active ulcerative colitis: a randomised placebo-controlled trial. Paramsothy S et al. Lancet. 2017 Mar 25;389(10075):1218-1228. doi: 10.1016/S0140-6736(17)30182-4.
Clinical remission in patients with moderate-to-severe Crohn's disease treated with filgotinib (the FITZROY study): results from a phase 2, double-blind, randomised, placebo-controlled trial. Lancet 2017 Jan 21;389(10066):266-275.
Comparison of Targeted vs Random Biopsies for Surveillance of Ulcerative Colitis-Associated Colorectal Cancer. Watanabe T et al. Gastroenterology. 2016 Dec;151(6):1122-1130.